HT
ONC

HAP Trading’s BeOne Medicines Ltd ONC Stock Holding History

HAP Trading’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-11,398
Closed -$2.51M – 1741
2022
Q4 		$2.51M Buy
+11,398
New +$2.09M 0.26% 99
2022
Q3 		– Sell
-21,243
Closed -$3.44M – 2136
2022
Q2 		$3.44M Buy
21,243
+10,091
+90% +$1.58M 0.17% 114
2022
Q1 		$2.1M Buy
+11,152
New +$2.37M 0.09% 195
2019
Q4 		– Sell
-11,761
Closed -$1.95M – 1522
2019
Q3 		$1.44M Buy
+11,761
New +$1.56M 0.12% 151

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

HAP Trading's ONC Position: Q1 2023 in Review

HAP Trading sold out of BeOne Medicines Ltd (ONC) in Q1 2023, closing a stake of 11,398 shares — an estimated $2.51M sold.

HAP Trading first reported a position in ONC in Q3 2019 and held it in 4 quarters. The position peaked at $3.44M in Q2 2022. 220 funds tracked by Wall St. Rank hold ONC as of Q1 2023.

  • HAP Trading reported no remaining BeOne Medicines Ltd position as of Q1 2023 after selling out during the quarter.
  • HAP Trading sold 11,398 BeOne Medicines Ltd shares in Q1 2023, an estimated $2.51M.
  • HAP Trading first reported a position in BeOne Medicines Ltd in Q3 2019 and held it in 4 quarters.
  • HAP Trading's BeOne Medicines Ltd position peaked at $3.44M in Q2 2022.
  • 220 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2023.

Based on HAP Trading's 13F filing for Q1 2023, filed 12 May 2023.